A Study of GNC-035 in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematological Malignancies

Condition:   Relapsed/Refractory Chronic Lymphocytic Leukemia Intervention:   Drug: GNC-035 Sponsor:   Sichuan Baili Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials